Journal of Dairy Science and Biotechnology (J. Dairy Sci. Biotechnol., ISSN 2384-0269; eISSN 2508-3635) publishes original papers or review articles covering topics of chemistry, biotechnology, processing and microbiology of milk and milk products since 1981
13 February 2019 in International Journal of Dairy Technology
Journal of Milk Science and Biotechnology (J. Milk Sci. Biotechnol., ISSN 2384-0269; eISSN 2508-3635) publishes original papers or review articles covering topics of chemistry, biotechnology, processing and microbiology of milk and milk products since 1981
30 September 2018 in Journal of Milk Science and Biotechnology
Journal of Milk Science and Biotechnology (J. Milk Sci. Biotechnol., ISSN 2384-0269; eISSN 2508-3635) publishes original papers or review articles covering topics of chemistry, biotechnology, processing and microbiology of milk and milk products since 1981
Background: Sodium‐glucose cotransporter‐2 (SGLT2) inhibitors are a novel class of anti‐hyperglycaemic agents.Objective: This study aimed to evaluate the safety and the adjuvant glycaemic control effect of an SGLT2 inhibitor, DWP16001, in diabetic dogs receiving insulin treatment.Methods: Nineteen diabetic dogs receiving insulin treatment (NPH, porcine lente and glargine insulin) were divided into two groups according to dosing frequency: DWP TOD group (n = 10) and DWP SID group (n = 9). In the DWP TOD group, 0.025 mg/kg of DWP16001 was administered once every 3 days, whereas, in the DWP SID group, 0.025 mg/kg of DWP16001 was administered once a day. Food intake was maintained during the trial period. Hypoglycaemia, ketoacidosis or unexpected life‐threatening reactions were assessed as adverse effects before and after DWP16001 administration. We compared insulin requirement reduction and blood glucose level control between two groups.Results: No specific adverse effects were observed during the clinical trial, and haematological parameter remained unchanged. Moreover, the fasting glucose levels and daily insulin dose in the DWP TOD group were lower than the pre‐administration values, but not significantly different for 8 weeks. Systolic blood pressure, fructosamine and insulin dose decreased significantly in the DWP SID group compared to the DWP TOD group at 8 weeks (p < 0.05) without affecting food consumption. Among these patients, 10 patients were monitored while receiving DWP16001 for 12 months (DWP TOD group n = 5, DWP SID group n = 5). The fasting glucose and fructosamine levels and daily insulin dose were reduced in both groups at 12 months compared with those before receiving DWP16001.Conclusion: When DWP16001, an SGLT2 inhibitor, was supplied to dogs with type 1 diabetes, no adverse effects were observed, and it was confirmed that the administered insulin dose can be reduced in controlling blood glucose.
31 March 2020 in Journal of Dairy Science and Biotechnology
Journal of Dairy Science and Biotechnology (J. Dairy Sci. Biotechnol., ISSN 2384-0269; eISSN 2508-3635) publishes original papers or review articles covering topics of chemistry, biotechnology, processing and microbiology of milk and milk products since 1981